← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	ONCS 101 DELISTED OncoSec Medical Incorporated ONCS	17	-6	-26%	$265K
102	102 MiNK Therapeutics INKT $50.7M	16	+5	+45%	$1.7M
103	103 IN8bio INAB $11.7M	15	-2	-12%	$2.77M
104	LGVN 104 Longeveron LGVN $4.78M	15	-1	-6%	$1.44M
105	105 BioRestorative Therapies BRTX $2.02M	13	-1	-7%	$900K
106	106 Estrella Immunopharma ESLA $23.3M	13	-10	-43%	$19.7M
107	KRBP 107 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	12	-4	-25%	$146K
108	108 Eterna Therapeutics ERNA $2.53M	11	-20	-65%	$1.19M
109	CYAD 109 DELISTED Celyad Oncology SA American Depositary Shares CYAD	8	0	0%	$3.24M
110	110 Coya Therapeutics COYA $102M	4	+4	–	$5.16M
111	111 Genenta Science GNTA $32.3M	4	+2	+100%	$264K
112	112 NewcelX Ltd NCEL $16.5M	4	0	0%	$7.47M
113	SCPS 113 DELISTED Scopus BioPharma Inc. Common Stock SCPS	1	-14	-93%	$7.49K
114	TCBP 114 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	1	-2	-67%	$324K
115	AGTC 115 DELISTED Applied Genetic Technologies Corporation AGTC	0	-45	-100%	$0
116	AKUS 116 DELISTED Akouos Inc AKUS	0	-64	-100%	$0
117	LOGC 117 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	0	-39	-100%	$0
118	RCOR 118 DELISTED Renovacor, Inc. RCOR	0	-27	-100%	$0
119	119 Artiva Biotherapeutics ARTV $296M	–	–	–	–
120	120 DELISTED CARGO Therapeutics CRGX	–	–	–	–
121	121 enGene Therapeutics ENGN $115M	–	–	–	–
122	122 FibroBiologics FBLG $7.08M	–	–	–	–
123	123 CytoMed Therapeutics GDTC $10.4M	–	–	–	–
124	124 Fractyl Health GUTS $55.2M	–	–	–	–
125	125 Kyverna Therapeutics KYTX $369M	–	–	–	–